Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel M. Shapiro is active.

Publication


Featured researches published by Daniel M. Shapiro.


Experimental Biology and Medicine | 1953

Antagonist Studies: Comparison of Desoxypyridoxine and Pyridoxine-Deficiency Therapy on Various Vitamin B6 Enzymes.

L. S. Dietrich; Daniel M. Shapiro

Summary 1. Mice receiving a vit. B6 deficient-high protein diet were observed to have significantly lower transaminase, dopa decarboxylase and cysteine desulfhydrase activities as compared to similar animals receiving an identical diet supplemented with pyridoxine. Cysteine desulfhydrase was the most sensitive to vit. B6 deprivation, followed by transaminase and dopa decarboxylase. 2. The administration of desoxypyridoxine to mice receiving an ad libitum stock diet containing adequate vit. B6 significantly decreased transaminase and dopa decarboxylase activity. However, cysteine desulfhydrase activity was uninhibited. 3. A possible explanation of the observed results is discussed, the potentialities of vitamin antagonists as precise chemotherapeutic agents being indicated.


Experimental Biology and Medicine | 1952

Combination chemotherapy of cancer: potentiation of carcinostatic activity of 8-azaguanine by 6-formylpteridine.

Daniel M. Shapiro; Jacob Kream; L. S. Dietrich

Summary 1. 2-Amino-4-hydroxy-6-formyl pteridine (6-formylpteridine), although non-carcinostatic by itself, augmented the carcinostatic action of 8-azaguanine against a mammary adenocarcinoma. This effect was found to be dependent upon a time interval between the injection of 6-formylpteridine and 8-azaguanine. 2. 6-Formylpteridine inhibited the in vitro deamination of 8-azaguanine by tumor extracts. Pre-incubation of enzyme with inhibitor was found to be essential for maximal inhibition. 3. It was postulated that the enhanced carcinostatic effect observed in vivo could be due to inhibition of 8-azaguanine deamination by 6-formylpteridine, since the deaminated product (8-azaxanthine) is non-carcinostatic. We wish to express our appreciation to Dr. J. M. Ruegsegger of the Lederle Laboratories, Pearl River, N. Y., for supplies of 8-azaguanine, and to Drs. R. O. Roblin, Jr., and J. M. Smith, Jr., of the American Cyanamid Co., Stamford, Conn., and Bound Brook, N. J., for 6-formylpteridine. We wish to acknowledge the technical assistance of Miss R. Fugmann, Miss P. Hayworth, Miss A. Atti, and Mrs. E. Zanar.


Experimental Biology and Medicine | 1956

In vitro Effect of Two Pantheine Analogues on Co-Enzyme A Requiring Systems.

L. S. Dietrich; Daniel M. Shapiro

Summary Omega-methylpantethine was observed markedly to inhibit sulfanilamide acetylation at concentrations which were ineffective against citrate formation in pigeon liver homogenates. With aliquots of the same homogenate. bis- beta-pantoylaminoethyl) disulfide was observed to inhibit citrate formation at concentrations which were ineffective against sulfanilamide acetylation. In either case, higher concentrations of these compounds were effective in inhibiting both systems.


Cancer Research | 1950

The Effect of 5-Amino-7-Hydroxy-1H-v-Triazolo (d) Pyrimidine (Guanazolo) on a Variety of Neoplasms in Experimental Animals

Alfred Gellhorn; Morris Engelman; Daniel M. Shapiro; Samuel Graff; H. B. Gillespie


Cancer Research | 1956

Quantitative Biochemical Differences between Tumor and Host as a Basis for Cancer Chemotherapy

Daniel M. Shapiro; L. S. Dietrich; Maurice E. Shils; A. Atti; E. Borries; Ruth A. Fugmann; V. Muller; P. Hayworth; E. Zanar


Cancer Research | 1951

Combinations of chemical compounds in experimental cancer therapy.

Daniel M. Shapiro; Alfred Gellhorn


Cancer Research | 1953

Quantitative Biochemical Differences between Tumor and Host as a Basis for Cancer Chemotherapy I. Vitamin B6

Daniel M. Shapiro; L. S. Dietrich; Maurice E. Shils; A. Atti; E. Borries; Ruth A. Fugmann; V. Muller; P. Hayworth; E. Zanar


Cancer Research | 1952

Combination Chemotherapy with 8-Azaguanine and Sex Hormones on a Mouse Mammary Carcinoma

Daniel M. Shapiro


Cancer Research | 1953

Combination Chemotherapy of Cancer: Potentiation of Carcinostatic Action of 8-Azaguanine by a Riboflavin Analog

L. S. Dietrich; Daniel M. Shapiro


Journal of the National Cancer Institute | 1957

Combination chemotherapy: synergism between a possible folic acid antagonist and ethionine on a solid tumor.

Daniel M. Shapiro; Ruth A. Fugmann

Collaboration


Dive into the Daniel M. Shapiro's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ruth A. Fugmann

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge